That said, multiple recent Cochrane reviews found that taking the GLP-1 medications offered by Ro — semaglutide and tirzepatide — can result in meaningful weight loss. Users lose an average of 11-16% of their body weight over six to sixteen months, depending on the medication.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up questions. Ro is a direct-to-consumer (DTC), membership ...

Adults with obesity who dread weekly injections now have a new option: a daily pill. The FDA approved Foundayo, the brand name for orforglipron, as the first oral tablet cleared specifically for chronic weight management in adults with obesity or overweight paired with at least one related health condition.

Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep those pounds off. If you’ve struggled to make ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and member of the Peloton community. When she's not creat..

Hers is a telehealth platform for women that offers access to GLP-1 weight loss medications. The service provides FDA-approved drugs, online provider communication, and a holistic approach through its app. Membership costs $149 per month after the first ...